DE50311778D1 - Mischsystem zur löslichkeitsvermittlung von pharmazeutischen wirkstoffen in polymermatrizes - Google Patents

Mischsystem zur löslichkeitsvermittlung von pharmazeutischen wirkstoffen in polymermatrizes

Info

Publication number
DE50311778D1
DE50311778D1 DE50311778T DE50311778T DE50311778D1 DE 50311778 D1 DE50311778 D1 DE 50311778D1 DE 50311778 T DE50311778 T DE 50311778T DE 50311778 T DE50311778 T DE 50311778T DE 50311778 D1 DE50311778 D1 DE 50311778D1
Authority
DE
Germany
Prior art keywords
matrix
polymer matrix
hybridized
polymermatrices
solubility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50311778T
Other languages
English (en)
Inventor
Jens Nierle
Christian Gaede
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Application granted granted Critical
Publication of DE50311778D1 publication Critical patent/DE50311778D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
DE50311778T 2002-03-22 2003-03-21 Mischsystem zur löslichkeitsvermittlung von pharmazeutischen wirkstoffen in polymermatrizes Expired - Lifetime DE50311778D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10212864A DE10212864B4 (de) 2002-03-22 2002-03-22 Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP2003/002953 WO2003080035A1 (de) 2002-03-22 2003-03-21 Mischsystem zur löslichkeitsvermittlung von pharmazeutischen wirkstoffen in polymermatrizes

Publications (1)

Publication Number Publication Date
DE50311778D1 true DE50311778D1 (de) 2009-09-17

Family

ID=27815869

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10212864A Expired - Fee Related DE10212864B4 (de) 2002-03-22 2002-03-22 Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung
DE50311778T Expired - Lifetime DE50311778D1 (de) 2002-03-22 2003-03-21 Mischsystem zur löslichkeitsvermittlung von pharmazeutischen wirkstoffen in polymermatrizes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10212864A Expired - Fee Related DE10212864B4 (de) 2002-03-22 2002-03-22 Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung

Country Status (7)

Country Link
US (1) US7256234B2 (de)
EP (1) EP1490038B1 (de)
AT (1) ATE438389T1 (de)
AU (1) AU2003229563A1 (de)
DE (2) DE10212864B4 (de)
ES (1) ES2328127T3 (de)
WO (1) WO2003080035A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10360592A1 (de) * 2003-12-19 2005-07-28 Beiersdorf Ag Pflastersystem zur Verabreichung von Antihistaminika
DE102004038533A1 (de) * 2004-08-09 2006-02-23 Beiersdorf Ag Wasserhaltige Polymermatrix aus hydrophoben Polymeren
DE102004039728A1 (de) * 2004-08-16 2006-02-23 Beiersdorf Ag Wirkstoffhaltiges Tape zur Behandlung von Gelenkerkrankungen
JP5015562B2 (ja) * 2005-12-13 2012-08-29 日東電工株式会社 貼付製剤
DE102006017574A1 (de) * 2006-04-13 2007-10-18 Beiersdorf Ag Mischsystem zur Steuerung der Flüssigkeitsaufnahme von Haftklebemassen
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
EP2349230A2 (de) * 2008-10-06 2011-08-03 Mylan Technologies, Inc. Amorphes transdermales system von rotigotin
DE102008060904A1 (de) 2008-12-09 2010-06-10 Beiersdorf Ag Wasserlösliche Wirkstoffe in Sprühpflaster
CN102711834B (zh) * 2008-12-24 2015-08-26 爱尔兰詹森科学公司 治疗hiv的可植入装置
US9303171B2 (en) 2011-03-18 2016-04-05 Tesla Nanocoatings, Inc. Self-healing polymer compositions
GB201120908D0 (en) * 2011-12-06 2012-01-18 Reckitt Benckiser Healthcare Patch containing non-steroidal anti-inflammatory drug
ITMI20121428A1 (it) * 2012-08-10 2014-02-11 Allergosystem S R L Dispositivo per applicazione topica di medicamenti o cosmetici
US11717593B2 (en) 2013-03-13 2023-08-08 Avery Dennison Corporation Improving adhesive properties
RU2560674C1 (ru) * 2014-02-21 2015-08-20 Общество с ограниченной ответственностью "Инновации ветеринарии" (ООО "ИнВет") Универсальное антибактериальное средство
JP6513800B2 (ja) 2014-10-21 2019-05-15 ザ プロクター アンド ギャンブル カンパニー 皮膚の外観を改善するためのキット
CN108348788B (zh) 2015-10-22 2021-11-05 宝洁公司 发泡膜的阻隔贴片和改善皮肤外观的方法
US10576023B2 (en) 2015-10-22 2020-03-03 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
US10751265B2 (en) 2017-01-09 2020-08-25 The Procter & Gamble Barrier patch with soluble film and methods of improving skin appearance
US10857076B2 (en) 2017-01-09 2020-12-08 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
JP6974922B2 (ja) 2017-01-09 2021-12-01 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 可溶性フィルムを有するバリアパッチ及び皮膚の外観を改善する方法
WO2018237214A1 (en) 2017-06-22 2018-12-27 The Procter & Gamble Company BEAUTY MASK FILMS COMPRISING A WATER SOLUBLE LAYER AND A VACUUM EVAPORATED COATING
US10751266B2 (en) 2018-03-19 2020-08-25 The Procter & Gamble Company Method of making a barrier patch with soluble film

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6397272A (ja) 1986-10-15 1988-04-27 Kiyoshi Ogawa 防錆皮膜形成方法
JPS6397202A (ja) * 1986-10-15 1988-04-27 Toray Ind Inc ポリエ−テルスルホン系樹脂半透膜およびその製造方法
US5273757A (en) * 1987-09-01 1993-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Apparatus for the delivery of substances, processes for the production thereof and use thereof
US5306502A (en) * 1987-09-01 1994-04-26 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Apparatus for delivering nitroglycerin to the skin, processes for the production thereof and the use thereof
DE3743946A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
DE3743947A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur gesteuerten abgabe von nicotin, verfahren zu ihrer herstellung sowie ihre verwendung
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
DE4112508A1 (de) * 1991-04-17 1992-10-22 Akzo Nv Synthetische hydrophile membranen und verfahren zu deren herstellung
US6024975A (en) * 1992-04-08 2000-02-15 Americare International Diagnostics, Inc. Method of transdermally administering high molecular weight drugs with a polymer skin enhancer
EP0695179A1 (de) 1993-04-22 1996-02-07 Minnesota Mining And Manufacturing Company Transdermale entzuendungshemmende zusammensetzung
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
DE19804604A1 (de) * 1998-02-06 1999-08-12 Beiersdorf Ag Vorrichtung zur Freigabe von Stoffen
DE19908787A1 (de) * 1999-03-01 2000-09-14 Labtec Gmbh Transdermale Applikation von ß2-Sympathomimetika zur Behandlung obstruktiver Atemwegserkrankungen
DE10012908B4 (de) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
EP1490038A1 (de) 2004-12-29
ES2328127T3 (es) 2009-11-10
AU2003229563A1 (en) 2003-10-08
US7256234B2 (en) 2007-08-14
ATE438389T1 (de) 2009-08-15
DE10212864B4 (de) 2005-12-22
EP1490038B1 (de) 2009-08-05
DE10212864A1 (de) 2003-10-09
WO2003080035A1 (de) 2003-10-02
US20050124743A1 (en) 2005-06-09

Similar Documents

Publication Publication Date Title
DE50311778D1 (de) Mischsystem zur löslichkeitsvermittlung von pharmazeutischen wirkstoffen in polymermatrizes
MXPA05003591A (es) Materiales basados en ciclodextrina, composiciones y usos relacionados a los mismos.
BR9908438A (pt) Tabletes de desintegração rápida
WO2004039428A3 (en) Transdermal delivery system for dried particulate or lyophilized medications
BG106455A (en) Antibiotic, antibiotic polymer composition
EA200401252A1 (ru) Микрочастицы лекарственных веществ
DE69528057D1 (de) Tocopherolzusammensetzungen zur Abgabe von biologisch aktiven Substanzen
DE69523044T2 (de) Block- und pfropfcopolymere und dazu gehöriges verfahren
RS20070511A (en) Modified release pharmaceutical compositions and processes thereof
DE69833000D1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
PT991407E (pt) Estabilizacao de benzimidazoles sensiveis a acidos com combinacoes de amino/ciclodextrinas
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
WO2007084460A3 (en) Pharmaceutical compositions with enhanced stability
ATE541587T1 (de) Konjugat-additionsreaktionen zur kontrollierten abgabe von pharmazeutisch wirksamen substanzen
EP1472230A4 (de) Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften
BRPI0410956A (pt) pelìculas com base em óxido de polietileno e sistemas de liberação de droga feitos delas
ATE329897T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
BR0011772A (pt) Conjugado de droga-oligÈmero, composição farmacêutica, método de solubilização de uma droga em uma microemulsão, e, métodos para fornecer um conjugado de droga ativa - hidrófilo e um conjugado de droga ativa - peg a um sìtio de um indivìduo
ATE292453T1 (de) Antivirale arznei
SE9704401D0 (sv) Matrix pellets for greasy, oily or sticky drug substances
UY27929A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
HRP20080178T3 (en) Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances
BR9812553A (pt) Formulação medicamentosa com liberação de substância ativa controlada
ATE241338T1 (de) Arzneistoffabgabesystem, insbesondere zur verabreichung von androgenen
SE9603480D0 (sv) Beredningsform för svårlösliga läkemedel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition